{
    "laboratory_examinations": [
        {
            "procedure_name": "Oxidative burst assay using dihydrorhodamine",
            "date": "Not specified",
            "findings": "Abnormal",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Chromosomal microarray studies",
            "date": "Not specified",
            "findings": "Confirmed the loss of a 1.1-Mb region in Xp21.1-p11.4, including XK and CYBB genes.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "PCR-based short tandem repeat sorted chimerism assay",
            "date": "Day +64 post-transplant",
            "findings": "Complete donor cell engraftment of the myeloid cell lineage with incomplete engraftment of the lymphoid lineage (21%).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Neutrophil oxidative burst assay",
            "date": "Post-transplant",
            "findings": "Normal",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Culturing of blood samples for growth",
            "date": "Not specified",
            "findings": "Samples from each autologous donation cultured for aerobic, anaerobic, and fungal growth.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Weekly recombinant human erythropoietin (rEPO)",
            "date": "4 weeks post-transplant",
            "findings": "Received weekly.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Autologous RBC transfusions",
            "date": "Day +11 and Day +13 post-transplant",
            "findings": "Two 5-ml/kg autologous RBC transfusions were required.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Chimerism of lymphoid cell line",
            "date": "Over 1-year post-transplant",
            "findings": "Continued mixed chimerism of the lymphoid cell line (65%).",
            "changes_over_time": "Not specified"
        }
    ]
}